Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Intrathecal TPA Infusion for IVH Clearance
NCT07643493Phase 4Enrolling by invitation
- Start
- Jul 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in Intraventricular hemorrhage (IVH). Started Jul 2026; status: enrolling by invitation.
02
Drugs
tissue-plasminogen activator
03
Conditions
Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on NCT07643493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07643493.